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ed oxygen tension (hypoxia)  induces  a  3-fold in- 
crease in stability of mRNA for tyrosine hydroxylase 
(TH),  the rate-limiting enzyme in catecholamine synthe- 
sis, in the pheochromocytoma  (PC12)  clonal cell line. To 
investigate the possibility that RNA-protein interac- 
tions are  involved in mediating this increase in stability, 
RNA gel shift assays were performed using different 
fragments  of  labeled TH mRNA and the 5-100  fraction of 
PC12 cytoplasmic  protein  extracts. We identified a se- 
quence  within the 3“untranslated  region of TH mRNA 
that  binds  cytoplasmic  protein.  RNase T1 mapping re- 
vealed  that the protein  was  bound to a 28 nucleotide 
long  sequence  that is located  between  bases 1551-1579  of 
TH mRNA.  Moreover, protein  binding  to this fragment 
was prevented with an antisense oligonucleotide di- 
rected  against bases 1551-1579  and subsequent RNase H 
digestion. This  fragment of the 3’-untranslated  region of 
TH mRNA is rich in pyrimidine nucleotides, and the 
binding of cytoplasmic  protein to this fragment  was re- 
duced by competition with other polypyrimidine se- 
quences including  poly(C)  but  not  poly(U)  polymers. Th  
binding  of the protein to TH mRNA was  increased  when 
cytoplasmic  proteins  were  extracted from  PC12 cells ex- 
posed to hypoxia  (5% 0,) for 24 h. Electrophoresis of the 
W cross-linked RNA-protein complex on SDS-polyac- 
rylamide  gel  electrophoresis  revealed  a  complex of 74 
kDa.  The potential role of this protein-TH mRNA inter- 
action in regulation of TH mRNA stability  during hy- 
poxia is discussed. 
Tyrosine hydroxylase (TH)’ (EC 1.14.16.2) hydroxylates L- 
tyrosine to L-dopa (1, 2) and is the rate-limiting enzyme in 
catecholamine  synthesis.  TH  activity (V,,,,,) is enhanced in a 
number of neural  and  neuroendocrine  tissues by reduced oxy- 
gen  tension  (hypoxia) (3-5). We reported  recently that TH  gene 
expression is stimulated  by  hypoxia in the 0,-sensitive  (type I) 
cells of the carotid body but  not in other  catecholamine  tissues 
such as the adrenal  gland  or  sympathetic  ganglia  (6). We also 
Grants HL  51078,  HL  33831, HL 34919, and HD 28948,American Heart 
* The present study was supported by National Institutes of Health 
Association Grant-in-aid 91-009960, and a research grant from the 
American Lung Association. The costs of publication of this article were 
defrayed in part by the payment of page charges. This article must 
therefore be hereby marked “advertisement” in accordance with 18 
U.S.C.  Section  1734  solely  to indicate this fact. 
1 Recipient of a  Parker B. Francis Fellowship. To whom correspond- 
ence should be addressed: Dept. of Physiology,  474  Medical  Research 
Bldg., University of North Carolina, Chapel Hill, NC 27599-7545.  Tel.: 
919-966-1204;  Fax:  919-966-6927. 
The abbreviations used are: TH, tyrosine hydroxylase; 3’-UTR, 3’- 
untranslated region(s); PBS, phosphate-buffered saline; b, base(s); bp, 
base paifis); EPO, erythropoietin; TAE, Tris acetate-EDTA  buffer. 
found that TH gene expression is enhanced  by  hypoxia  in  phe- 
ochromocytoma  (PC121  cells,  which are biochemically and  mor- 
phologically similar to carotid body type I cells (7). Further 
studies in PC12  cells  revealed that reduced 0, tension  led  to 
increases  in  both t e rate of TH  gene  transcription  and  stability 
of TH mRNA (9). The present  study  was  undertaken  to  identify 
potential molecular mechanisms that might mediate the in- 
crease  in  TH  mRNA  stability  during  hypoxia. 
Messenger  RNA  stability (i.e. rate of degradation)  is an im- 
portant  mechanism  for  regulation of gene  expression  (for  re- 
view, see Refs. 8-10). The  turnover of mRNAs  is  regulated  by 
interactions among trans-acting factors (regulatory proteins) 
and specific sequences  located  mainly  within  the  3”untrans- 
lated  regions  (3’-UTR) of some  mRNAs. In recent  years a num- 
ber of unique  cis-acting  elements,  such as the iron-responsive 
elements (11) and adenosine/uridine(AU)-rich sequences (12, 
13),  have  been  shown  to  bind  cytosplamic  proteins.  These  ele- 
ments  have  been  implicated in regulation of mRNA  stability  in 
eukaryotic cells. We hypothesized that increased  stability of TH 
mRNA  during  hypoxia is mediated  by the interaction of a cy- 
toplasmic  protein(s)  with a unique  cis-element  on  the  3’-UTR of 
TH mRNA. Computer analysis of the 3’-UTR of TH mRNA 
revealed that i t  does  not  contain  any of the identified  consensus 
elements  (IRE or AU-rich  sequences)  normally  associated  with 
mRNA stability. In the present study we report that a 28-b 
pyrimidine-rich sequence within the 3’-UTR of TH mRNA 
binds cytoplasmic protein(s). Importantly, this interaction is 
enhanced  when  proteins  are  extracted  from  PC12  cells  exposed 
to  hypoxia. 
MATERIALS AND METHODS 
Cell Culture and Preparation of Cytoplasmic Extracts-Rat PC12 
cells  were  grown as described  previously (7). When  cells  reached  90% 
confluency they were exposed to either normoxia (21% 0,, 5% CO,, 
remainder N,) or hypoxia (5% 0,, 5% CO,, remainder N,) in an 0,- 
regulated incubator (Forma Sci., Inc.) for 18 h. 
The S-100 fraction of cytosolic proteins was obtained as described 
(14). Following exposure to either normoxia or hypoxia,  cells  were col- 
lected and washed in ice-cold  PBS (pH 7.5) and then  in  5 volumes of 
hypotonic  buffer containing 15 m~ Tris (pH 7.9), 10 mM KC1, 0.2 m~ 
EDTA (pH 8), 0.5 m~ dithiothreitol, and 0.5 m~ phenylmethylsulfonyl 
fluoride.  Cells  were then centrifuged and lysed in 3 volumes of the same 
hypotonic  buffer  for  10 min. The  cells  were  homogenized  with 20 strokes 
of Dounce  homogenizer (pestle B), the nuclei  were separated by cen- 
trifugation, and the remaining cytoplasmic lysates were extracted with 
0.11  volume of 10 x cytoplasmic  buffer (0.3 M Hepes, pH  7.9,  1.4 M KC], 
0.03 M MgCl,). The extracts were then centrifuged at 100,000 x g  at 4 “c 
for 60 min and dialyzed  for 5  h  in  the  2 x binding buffer (see below) at 
4 “C. Protein yield  (Bio-Rad assay) was  normally in  the range of 5-15 
pg/pl. We did  not  observe  differences in  the protein yield obtained from 
PC12 cells exposed to normoxia and hypoxia. The extracts were ali- 
quoted and stored frozen at -80 “C. 
Plasmid Constructs and RNA Zkanscripts-ATH  cDNAin SP64 plas- 
mid (pSPTH-3) (Fig. lA) was used to generate fragments of TH  mRNA. 
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A 600-base pair (bp) EcoRIlBamHI fragment of TH  cDNA that contains 
the last 300  bp of the coding  region and  the  entire 3'-UTR  was cut from 
the pSPTH-3  vector and subcloned into EcoRI-BamHI sites of the  tran- 
scription vector  PBS+/- phagemid (Stratagene). We refer to this vector 
as PBS-TH6OO. A 162-bp  KpnVSphI  (1521-1682) fragment of TH  cDNA 
that encodes the region in  the 3'-UTR of TH  mRNA was cut from the 
pSlTH-3  vedor and subcloned into the same restriction sites of vector 
SP73 (F'romega  Corp.). This clone  (pSP73-TH162) was sequenced and 
found to be identical with the published sequence of TH  cDNA (15). Our 
cloning strategy allowed us to generate three different transcripts for 
use in RNA-protein-binding reactions (Fig. IA). A 1200-b  long fragment 
of TH  mRNA,  which contained most of the coding  region  for  TH  mRNA, 
was obtained by transcription from the original pSFTH-3 plasmid lin- 
earized with EcoRI. A 600-b fragment of TH  mRNA that contained the 
remainder of the coding  region and  the  entire 3'-UTR was generated by 
transcription from plasmid PBS-TH6OO linearized with BamHI. The 
162-b fragment from the 3'-UTR of TH  mRNA was obtained by tran- 
scription from plasmid pSP73-TH162 linearized with HindIII, which is 
located  2-bp 3' from the SphI site. In addition, a nonspecific mRNA of 
138-b was obtained from the SP73 vector DNA linearized with HpaI. 
In vitro transcriptions were  performed using SP6 polymerase (Pro- 
mega  Corp.)  for the SP64 and SP73 vectors and T7 polymerase (Pro- 
mega Corp.) for the PBS  vector. In vitro transcription of the  test frag- 
ments was  performed in the presence of 50 pCi of [CY-~~PIUTP 
(Amersham Corp.; 3000 > CUmmol), 2.5 m~ of all four unlabeled nucle- 
otides, 20 m~ dithiothreitol, 2 mg/ml of bovine serum albumin, RNasin, 
and the appropriate polymerase at 40 "C for 60 min. Unlabeled RNA 
that was synthesized as described  above but without radioactive nucle- 
otide  was used in competition experiments. Following in vitro transcrip- 
tion, the template DNA was digested with RNase-free  DNase  (Boeh- 
ringer Mannheim), and the RNA was purified on a RNase-free G-50 
column (Boehringer Mannheim). In all cases a single RNA band of the 
appropriate size was resolved on a  denaturing polyacrylamide  gel. 
In some RNA binding experiments competitor RNA that contained a 
polypyrimidine  (poly(Y)')  sequence was transcribed from  clone 
DUF'33Y5 linearized with NcoI (16). The same competitor RNA that did 
not contain the poly(Y)  sequence (poly(Y)-) was transcribed from the 
same vector cut with MboII. In other competition experiments, RNA 
homopolymers of poly(C) or poly(U) (Pharmacia LKB Biotechnology 
Inc.) were used. 
sequences (1551-1579 and 1633-1659)  located within the 3'-UTR of TH 
The antisense oligodeoxyribonucleotides that were complementary to 
mRNA were used in the binding reactions. The sequences of these 
oligonucleotides  were 5"AGAGGTAGGGGAAGAGGTTGGAAAGG- 
AC-3' and 5'-TGGGGGTAGGAGGGlTGTGACGAAGAG-3'. Oligo- 
nucleotides were synthesized in our laboratory on a DNA synthesizer 
(Millipore). 
RNA-Protein-binding Reaction and Electrophoresis of Complexes- 
Binding reactions were performed essentially as described by others 
(17-18).  Cytoplasmic proteins (5-40 pglreaction) were incubated in 10 
mM Hepes, pH 7.9,5 m~ MgCl,, 50 m~ KCl,  200 ng/pl ofEscherichia coli 
tRNA,  10% glycerol, and 1 mM dithiothreitol at 30 "C for 20 min. Spe- 
cific RNA transcripts (40,000-100,000 cpmheaction) were added, and 
the binding reaction in  total volume of  30 pl  was incubated for 30 min 
at 30  "C.  For the competition experiments, proteins were incubated first 
(15 min) with the indicated amounts of competitor RNA and then with 
the labeled RNA for an additional 15 min. The indicated amounts of 
antisense oligonucleotides  were added simultaneously with the labeled 
TH  mRNA fragment. After  completion of the binding reaction, RNase 
T1 (20 units, RNase  T1,  Calbiochem) and  heparin sulfate (to the final 
concentration of 5 mg/ml)  were added sequentially to  the reaction mix- 
ture for 10 min each at 30  "C. In some experiments the binding reaction 
was treated with Proteinase K (Boehringer Mannheim; final concentra- 
tion, 2 mg/ml,  30 min, 37  "C). Electrophoresis of RNA-protein  complexes 
was carried out on  7% native polyacrylamide  gel (acrylamide/methylene 
bisacrylamide ratio, 60:l) with 0.5 x Tris borate-EDTA  buffer. The gels 
were preelectrophoresed for 1 h at 8 V/cm  followed  by electrophoresis of 
RNA-protein  complexes  for 2  h at 35 A. Gels  were dried and exposed to 
x-ray film (Kodak). The quantitative assessment of RNA-protein bands 
was performed by optical density measurements (Image Pro11 Plus)  and 
Student's t test for statistical analysis. 
RNase T1 Mapping-The binding reaction between the 162-b frag- 
ment of the 3'-UTR of TH mRNA and cytoplasmic proteins was per- 
formed as described  above.  Following electrophoresis of the RNA-pro- 
tein complex, the gel  was  exposed  to  x-ray  film at  4 "C overnight, and 
the location of specific  RNA-protein bands was determined. The iden- 
tified bands were cut out of the gel and transferred to a dialysis bag, and 
the RNA was electroeluted into 1 x TAE buffer using 150 V for 2 h at 
4 "C. This procedure allowed  for isolation of the RNA fragments that 
were  bound  to proteins and thus protected from  RNase T1 digestion. 
The isolated RNA was phenol/chloroform-extracted and ethanol-precipi- 
tated using yeast tRNA as a carrier. 600-1500  cpm  of labeled RNA were 
usually recovered. The entire 162  TH  mRNA fragment (not bound  to the 
protein) as well as half of the eluted RNA  were digested with RNase T1 
(10 units, 37  "C,  30 min). The  RNase  T1-digested entire 162-b fragment 
as well as the nondigested and  the RNase  T1-digested fragment of  RNA, 
which  was eluted from the RNA-protein  complex,  were  electrophoresed 
on a 12% denaturing polyacrylamide  gel.  The  gel was dried and exposed 
to  x-ray  film overnight at -80 "C. A comparison of the sequences of the 
RNase T1-digested fragments from the eluted RNA and the 162-b frag- 
ment not incubated with the proteins allowed  for identification of se- 
quences in  the 162-b fragment of the 3'-UTR of TH  mRNA,  which  were 
protected from  RNase T1 digest by bound proteins (17). 
W-Cross-linking and Electrophoresis of RNA-Protein Complexes- 
RNA-protein-binding reactions were performed as described above. 
Open  microcentrifuge tubes containing the binding reactions were ir- 
radiated with a total of 4 x lo6 J/cm2 of UV light ( U V  cross-linker FB 
UVXL-1000; Fisher Sci., Inc.), boiled in SDS sample buffer without 
P-mercaptoethanol, and electrophoresed on an 8% SDS-polyacrylamide 
gel along with prestained protein molecular  weight markers (Bio-Rad). 
The gels  were dried and then exposed overnight to x-ray film at -80 "C. 
The size of RNA-protein  complex was determined using RFLP  molecu- 
lar weight software (DNA ProScan Inc.). 
RESULTS 
RNA gel  retardation  assays  were  performed  to  determine the 
binding  pattern of cytoplasmic  proteins to TH mRNA. Binding 
reactions were performed  using three separate  fragments of rat 
TH mRNA, which  encompassed  the ntire length of this mRNA 
(Fig. lA). Fig. 1B shows that the addition of the S-100 fraction 
of cytoplasmic protein extract (CPE) retarded migration of 
RNA in  the  form of smear  (lane 2 ) ,  which  was  resolved  into a 
single band after  addition of RNase T1 ( R T l )  and heparin ( H )  
(lane 3)  to the binding  reaction.  This  band  was  abolished  by 
treatment of the binding  reaction  with  Proteinase K (PK, lane 
4 ) .  This  result  indicates that the observed band (lane 3)  was 
due  to  interaction of a protein(s)  with the labeled RNA. Fig.  1C 
shows that a band at the same  level  was  obtained  when either 
the 162- or 600-b TH mRNA  fragments  were  used  (compare 
lanes 3 with 2 ). Note,  however, that this band was  not  observed 
when the 1200-b fragment of TH mRNA  (lane 1 ) was  used. A 
nonspecific band was  detected  when the plasmid SP73 RNA 
(lane 4 )  was  used.  The similar binding  pattern  obtained  with 
both the 162- and 600-b fragments of TH mRNA is due to 
inclusion of the 162-b fragment  within the 600-b  fragment  (Fig. 
lA). The binding of protein  to the 162-b fragment  was  propor- 
tional  to the amount of protein  extract  used  (Fig. 2 . 4 )  and also 
to the amount of probe used at a constant concentration of 
cytoplasmic  extract  (not  shown). 
To determine if the observed  RNA-protein  complex  is specific, 
competition experiments were performed using nonlabeled, 
specific (162-b fragment of 3'-UTR) and nonspecific plasmid 
mRNA. Fig. 2B shows the results  from  one  such  experiment. 
The binding of protein  to the 162-b fragment of the 3'-UTR of 
TH mRNA  (lane 2 )  was  reduced  or  abolished after addition of 
10 x and 50 x molar  excess of nonlabeled, specific mRNA to the 
binding  reaction  (lanes 3-6). In contrast,  competition  with the 
same  concentration of nonspecific plasmid RNA had no  effect 
on the binding  activity  (lanes 7-10). 
To determine if exposure of PC12 cells  to  hypoxia  affects  the 
binding of protein  to the 162-b  fragment,  gel  retardation  assays 
were  performed using the S-100  fraction of cytoplasmic  protein 
extracted from PC12 cells exposed for 18 h to either 5% 0, 
(hypoxia) or 21% 0, (normoxia).  Fig. 3A shows that the  forma- 
tion of the 162-b RNA fragment-protein  complex  was  substan- 
tially increased when extracts from hypoxic cells were used 
(lane 2 )  as compared  with  extracts  taken  from  normoxic  cells 
(lane 1 ) .  This difference was approximately 2.5-fold and  was 
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FIG. 1. A, restriction  map of rat TH cDNA. Open areas represent the 
5’- and 3’-UTR, and  the dashed area represents the coding region. 1200, 
600, and 162  represent  fragments of TH mRNA obtained from in vitro 
transcription as described under  “Materials and Methods,” which were 
used in  the gel retardation assays. B and C ,  formation of specific TH 
mRNA-protein  complexes (arrows). Addition of cytoplasmic protein ex- 
tracts (CPE)  (40 pg)  to the labeled RNA resulted in a smear-like shift 
heparin ( H )  and RNase T1 ( R T l )  (panel B, lane 3) .  Treatment with 
(panel B, lane 2), which resolved into  a single band after addition of 
proteinase K (PK) abolished the band (panel B, lane 4 ) .  The specific 
band was present only when the 600 or 162-b TH mRNA fragments 
were used (panel C, lanes 2 and 3 )  but not when the 1200-b TH or 
plasmid Sp73 mRNAs were used (panel C ,  lanes 1 and 4) .  
statistically significant ( p  < 0.001, n = 13, Fig. 3B). 
To identify the sequence within the 162-b fragment that 
forms the RNA-protein complex, RNase T1 mapping assays 
were performed. RNase T1 digests RNA after each G residue. 
Results from these  experiments are shown in Fig. 4. The RNase 
T1 digest of the  entire 162-b TH mRNA fragment, which was 
not incubated with proteins, is presented in lane 1, and its 
sequence is given in Fig. 4B. The RNase T1 digestion of the 
162-b fragment gives two relatively long G-free regions of 28 
and  21 b (lane 1) .  Fig. 4A, lane 2, shows the TH mRNA frag- 
ment  that  was  eluted from the gel band following gel retarda- 
tion assay, and lane 3 shows the  eluted RNA after additional 
digestion with  RNase T1. The RNA fragment  that was eluted 
from the gel following the gel retardation  assay  migrates as a 
28-b fragment (compare lanes 2 and 1 ), which is not  digested 
further by RNase T1 (lane 3) .  The sequence of this 28-b frag- 
ment is indicated with bold and underlined letters, and  the 
sequence of the 21-b, G-free fragment is underlined in Fig. 4B. 
The results from this experiment  indicate that  the 28-b G-free 
fragment located between 1551-1579-b of  3’-UTR  of TH mRNA 
binds to cytoplasmic protein.  Identical results were obtained 
when either normoxic or hypoxic S-100 extracts were used for 
the RNase T1 mapping study. 
To confirm that formation of the TH mRNA-protein complex 
involves the 28-b fragment, we performed selective RNase H 
cleavage of this  fragment by addition of an  antisense oligode- 
oxyribonucleotide that was complementary to the 28-b frag- 
Cytoplasmic  protein  extract 
(PC12cells) 
40 20 10 5 2.5 ~ u g  
- amm- 
1 2 3 4 5 6  
Competitor: 162 THmRNA Sp73 mRNA -
0 lox 20x 50x IOOX ’ lox 20x 50x loo: 
1 2 3 4 5 6  7 8 9 1 0  
FIG. 2. A, the size of the RNA-protein  complex was proportional to the 
amount of the protein used (indicated amounts of cytoplasmic protein 
extract are shown) (lanes 2-6). B, the binding of protein to TH mRNA 
was reduced and abolished with nonlabeled 162-b TH mRNA (left)  but 
not with nonlabeled plasmid Sp73 mRNA (right). 
A. 
C H  
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1 2  
FIG. 3. Effects  of  hypoxia on the  formation  of TH mRNA pro- 
tein complex. A, RNA gel retardation  assay using cytoplasmic protein 
extracts (CPE)  (20 pg) from  PC12 cells exposed to normoxia ( C )  (lane 1 )  
or hypoxia (HI (lane I ) .  B, averaged results (means = S.E.) were ob- 
tained from optical density measurements in 13 independent experi- 
ments (normoxia, white bar; hypoxia, black bar). Hypoxia significantly 
increased formation of RNA-protein  complex by  2.5-fold ( p  < 0.001). 
ment. Following hybridization of the  antisense oligonucleotide 
to the 28-b fragment of  RNA, the RNA moiety was digested by 
RNase H present  in  the protein extracts (19). If the 28-b frag- 
ment is involved this should  prevent  protein binding. Results 
from this experiment show that  this is indeed the case (Fig. 5). 
Hypoxia-mediated  Binding of a Cytoplasmic  Protein to TH mRNA 9943 
A. R:’ RT 1 
28*- I, a - 
13- 
12- - 
I I -  * 
9- 
7- 
B. (1519) 5’  UACCACCCACggUgCCAgggCCUUUCCCAAAg 
~AUCCCCWCUCCAACCICCI,!ggCCCAgAggCUUUCCCAUgUgUgU 
ggCUgggCCCUUUgAUgggCUCCUCUU~CCCCAUCCUCCCAACAC~CUUC 
UCAACCAUgUCUUACUACUgCAUg 3’ (1681) 
FIG. 4. Identification  of the sequence on TH mRNA that  binds 
protein using RNase T1 mapping. A, lane 1, RNase T1  digest of the 
162-b fragment of TH mRNA; lane 2, fragment of protected  TH mRNA 
eluted from the RNA-protein complex; lane 3, eluted,  protected RNA as 
in lane 2 was  further  digested  with  RNase T1. RNA size  markers  are 
indicated  in  nucleotides. Asterisk indicates  the  protected  sequence. B,  
the sequence of the 162-b fragment of TH mRNA from base  1519  to 
1681. The  protected  sequence is bold and underlined. The 21 nucleotide 
G-free  fragment  is underlined. 
Antisense oligodeoxynucleotides 
anti-28 anti-21 
0 2 20 50 ’ 2 20 50 ‘ng -
c 
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FIG. 5.  Inhibition of the TH mRNA-protein  complex  formation 
with oligonucleotide antisense to the 28-b fragment of TH 
mRNA. Addition of indicated  amounts (lanes 3 5 )  of the 28-b antisense 
oligonucleotide prevented  formation of the complex. Addition of an  an- 
tisense oligonucleotide that was complementary to the 27 b of TH 
mRNA (1633-1659 b) did  not  prevent  formation of specific complexes 
(lanes 6-8). 
Addition of  2-50 ng of the  antisense oligonucleotide resulted  in 
a substantial reduction in formation of the specific complex 
(lanes 3 4  ). However, addition of an  antisense oligonucleotide 
complementary to  bases 1633-1659 of TH mRNA (this region 
contains  the 21-b long G-free fragment  that sometimes yields a 
weak  band in RNase T1  assay) did not  cause reduction of the 
RNA-protein complex formation (lanes 5-7). This  result  is fur- 
ther evidence that  the 28-b fragment identified by RNase T1 
digestion is  the protein-binding site  in  TH mRNA. 
Analysis of this 28-b fragment of TH mRNA revealed that  it  
is rich in pyrimidine ribonucleotides (86%). Recent findings 
have shown that pyrimidine-rich sequences bind proteins in- 
volved in RNA processing (for review, see Ref. 20). We therefore 
A. Competitor RNA 
+ poly (Y 1 
0 ‘15% 60x1 
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FIG. 6. Competition  of TH mRNA-protein binding  with poly- 
pyrimidine RNA. A, formation of the specific TH mRNA protein com- 
plex was competed with the RNA containing  a  string of 28  pyrimidines 
(lanes 3 and 4,poly(YY)  but  not  with  the  same RNA that did  not  contain 
a polypyrimidine sequence (lanes 5 and G,poly(Y)-) .  B,  the binding  was 
competed with poly(C) homoribopolymer (lanes 3 5 )  but not with 
poly(U) homoribopolymer. The  amounts of competitior RNA are indi- 
cated. 
performed experiments to determine if protein interactions 
with  the 162-b fragment is reduced by competition with other 
pyrimidine-rich sequences. Results from these experiments are 
shown in Fig. 6. Protein binding was reduced when nonlabeled 
RNA that contained a fragment of 28  pyrimidines (poly(Y)+; 
Fig. 6 A ,  lanes 3 and 4,) but not  with the  same RNA lacking the 
poly(Y) sequence (poly(Y)-; lanes 5 and 6 )  was added to  the 
binding  reaction.  Interestingly, the binding  was  also competed 
by poly(C) but not by poly(U) homopolymers (Fig. 6B). This 
finding  indicates that  the TH mRNA-binding protein shows a 
high  affinity for poly(C) sequences. 
To determine  the size of TH mRNA-protein complexes, the 
UV-cross-linking was performed, and  the products were ana- 
lyzed on an SDS-8% polyacrylamide gel. As shown in Fig. 7 one 
major RNA-protein complex of approximately 74 kDa was  re- 
solved. This complex occasionally appeared  as a doublet. The 
complex was not observed after the binding reaction was 
treated with Proteinase K (lane 8). Moreover, the complex was 
abolished when excess (150 and 250 ng) of nonlabeled specific 
162-b TH mRNA was used as competitor (lanes 2 and 3) .  Ad- 
dition of the same concentration of nonlabeled, nonspecific 
plasmid RNA did not  interfere with UV cross-linking (lanes 4 
and 5). The formation of the 74-kDa complex was substantially 
increased when protein extracts used for UV cross-linking were 
from PC12 cells that  had been exposed to hypoxia (compare 
lanes 6 with 7). This finding corresponds with the increased 
binding observed in  the RNA gel retardation  assays when pro- 
tein  was  extracted from PC12 cells that  had been exposed to 
hypoxia (see Fig. 3). The 74-kDa complex contains 28 nucleoti- 
des of RNA, which accounts for approximately 8 kDa of the 
complex. Thus  the approximate  size of the binding  protein is 
approximately  66 kDa. We have also occasionally observed a 
smaller  band  representing  an RNA-protein complex of 53 kDa 
(not shown). This complex was not  regulated by hypoxia. 
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FIG. 7. Identification of TH mRNA-protein  complexes using W 
cross-linking. A major band of 74 kDa was identified (arrow). The 
appearance of the 74-kDa band was abolished by addition of nonlabeled 
162-b TH  mRNA (lanes 2 and 3) but not by nonlabeled plasmid Sp73 
mRNA (lanes 4 and 5). The UV cross-linked complex was substantially 
increased when cytoplasmic protein extracts were used from PC12 cells 
that had been exposed to hypoxia (H) rather then normoxia (C) (com- 
pare lanes 6 with 7). Treatment with Proteinase K (PK) (lane 8) pre- 
vented appearance o f  the TH mRNA-protein complex. 
DISCUSSION 
In  the  present  study we showed that  the 3'-UTR of tyrosine 
hydroxylase mRNA contains a novel cis-element that  interacts 
with cytoplasmic protein(s).  Importantly, we showed that  this 
interaction is augmented by hypoxia. We propose that this 
RNA-protein interaction  is involved in  regulation of TH mRNA 
turnover  during normoxia and hypoxia (7). 
We have identified a 28-b fragment located within  the 3'- 
UTR of TH mRNA that is the  site of protein  binding. The  exact 
sequence  within the 28-b fragment  that is required for protein 
binding was  not  determined  in  the  present study. However, this 
sequence is pyrimidine-rich (86%) and contains an uninter- 
rupted sequence of 11 pyrimidines, and the protein-binding 
activity can be  reduced substantially by competition with  se- 
quences that  contain long stretches of pyrimidines. These  data 
indicate  that  the pyrimidine-rich feature of this  fragment  may 
be directly involved in protein binding. Computer  analysis of 
the 3'-UTR TH mRNA shows that  this 28-b sequence  may  be 
located within a stem-loop secondary structure, which is a com- 
mon feature of  RNA binding sequences. 
The 28-b protein-binding fragment of the 3'-UTR of TH 
mRNA is highly homologous with a fragment of 3'-UTR of 
erythropoietin (EPO) mRNA that binds a cytoplasmic protein 
(ERBP) (18). It  has been proposed that  this sequence is in- 
volved in  regulation of EPO mRNA stability in Hep3B cells 
(18). The region of  EPO mRNA that  binds  ERBP  contains a 
fragment (782-811 b)  that is pyrimidine-rich (66%), with an 
uninterrupted sequence of 9 pyrimidines (bases 794-801). The 
sequence from base 789 to 811 is highly homologous (72%)  with 
the identified  protein-binding  sequence in  the 3'-UTR of TH 
mRNA. 
Long polypyrimidine tracts are usually  present  within in- 
trons, immediately upstream from the 3' splicing site. It  has 
been  shown that  these polypyrimidine tracts  participate  in  the 
splicing of various pre-mRNAs (21, 22). In  addition, 5' tran- 
script  leaders of ribosomal proteins mRNAs and  several  other 
mRNAs under translational control contain polypyrimidine 
tracts (23, 24). The identified  pyrimidine-rich fragment of 3'- 
UTR of TH mRNA is located within  the  terminal exon (exon 13) 
of TH pre-mRNA, which to date  has  not been shown to be 
involved in  alternative splicing (25, 26). We therefore suggest 
that  the identified  pyrimidine-rich  sequence in  the 3'-UTR of 
TH mRNA represents a novel element  that  regulates  the  turn- 
over of TH mRNA. 
Results from W cross-linking experiments revealed that a 
66-kDa cytosplamic proteins  binds to the identified  sequence of 
TH mRNA. It  does not exclude the possibility that  other pro- 
teins are involved in  the TH mRNA-protein complex via a pro- 
tein-protein  type of interaction.  Interestingly, the 66-kDa pro- 
tein corresponds  approximately in size to  the 70-kDa protein, 
which was shown to bind to  the 3'-UTR of EPO mRNA (18). 
However, in  contrast  to  our  results, no increase  in  the forma- 
tion of the  EPO mRNA-protein complex was observed during 
hypoxia (18). 
Several polypyrimidine tract-binding proteins have recently 
been identified and characterized (for review, see Ref. 20). 
There is evidence that  these  proteins  are located in  the nucleus 
and are part of the RNA splicing apparatus (pPTB) (21, 22) or 
a member of family of proteins referred to as heterogenous 
nuclear ribonucleoprotein  particles (I (27); C1  and C2 (28); K 
and J (29)). In  this  regard, C  proteins show high  affinity for the 
poly(U) (301, whereas  the K and J proteins show high  affinity 
for the poly(C) tracts (29). In  the cytoplasm a 56-kDa protein 
has been  identified that  binds  to  the polypyrimidine sequence 
of the mRNA, which encodes ribosomal r-protein (24). It  is 
difficult to determine if the  TH mRNA-binding protein  repre- 
sents one of the earlier characterized polypyrimidine tract 
binding  proteins. It should be noted that  there is similarity in 
the size of the  TH mRNA-binding protein  (66 kDa)  and  the 
68-kDa K or J heterogenous nuclear ribonucleoprotein particles 
(29)  and  to a lesser  extent with  57-62-kDa pPTB (21, 22, 27). 
However, in  contrast  to  the pPTB that can be competed from 
poly(Y) binding by poly(U) homopolymers (221, the binding to 
the  TH mRNA can only be prevented by  poly(C) homopolymers. 
Therefore, the binding properties of the TH mRNA-binding 
protein appears to be more similar  to  the K or J proteins (29). 
Because these  proteins  are found in  the nucleus rather  than  in 
the cytoplasm (291, the  TH mRNA-binding protein  may be dif- 
ferent  and may represent a novel class cytoplasmic polypyri- 
midine-binding  proteins. 
The functional significance of the TH mRNA-protein binding 
was not elucidated in the present study. However, a major 
finding in the present study was that the intensity of TH 
mRNA 66-kDa protein-binding complex was increased during 
hypoxia. In view of the increased stability of TH mRNA and  the 
increased  binding of the 66-kDa protein to the 3'-UTR of TH 
mRNA measured  during hypoxia, it  is  tempting to hypothesize 
that  the binding of the 66-kDa protein is involved in regulation 
of TH mRNA stability.  Interestingly, it was  reported  recently 
that the polypyrimidine tract-binding protein, heterogenous 
nuclear ribonucleoprotein particles I, binds to nuclease hyper- 
sensitive regions of the heterogeneous nuclear RNA-protein 
complexes (27).  Therefore, it  might be that  the pyrimidine-rich 
tracts are nuclease  hypersensitive and  participate  in  the deg- 
radation of  RNA. The binding of protein(s)  may  protect these 
sensitive regions from nucleases and  thus promote stability of 
mRNAs that contain these binding  sequences. 
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